Tobradex Eye Drops - Summary of Product Characteristics (SmPC)
Tobradex Eye Drops - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd
www.medicines.org.ukHere’s a concise update on Tobradex eye drops.
If you’d like, I can pull the latest patient-facing guidance or summarize a specific country’s labeling (e.g., FDA, EMA, or local regulatory documents) and tailor it to your location. Do you want that, and is there a particular country or context you’re interested in?
Citations:
Tobradex Eye Drops - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd
www.medicines.org.ukDrug Review Package
www.accessdata.fda.govTOBRADEX® ST is a topical antibiotic and corticosteroid combination for steroid-responsive inflammatory ocular conditions.
www.tobradexst.comIn case patients are allowed to wear contact lenses, they must be instructed to remove contact lenses prior to application of TOBRADEX Eye Drops and wait at least 15 minutes before reinsertion. As the possibility of adverse effects on the corneal permeability and the danger of disruption of the corneal epithelium with prolonged or repeated usage of benzalkonium chloride
www.novartis.comTobradex Eye Drops - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd
www.medicines.org.uk